Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Postoperative Cervical Cancer (AMICA-CC) : a Prospective, Multicenter, Phase II Trial

NCT07684508 is registered in ClinicalTrials.gov with Manni Huang as lead sponsor.

NCT NCT07684508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07684508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Postoperative Cervical Cancer (AMICA-CC) : a Prospective, Multicenter, Phase II Trial
Lead sponsor
Manni Huang
Phase
Not applicable
Overall status
Recruiting
Start date
July 10, 2026
Completion date
December 30, 2030
Enrollment
154 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancers, hypofractionated radiotherapy, intensity-modulated radiotherapy